Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Kobayashi Pharmaceutical Co., Ltd.
  6. Summary
    4967   JP3301100008

KOBAYASHI PHARMACEUTICAL CO., LTD.

(4967)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
10/20/2021 10/21/2021 10/22/2021 10/25/2021 10/26/2021 Date
8720 8610 8620 8530 8530 Last
79200 67900 79000 85200 70200 Volume
-0.68% -1.26% +0.12% -1.04% 0.00% Change
Estimated financial data (e)
Sales 2021 157 B 1 383 M 1 383 M
Net income 2021 19 731 M 173 M 173 M
Net cash position 2021 103 B 904 M 904 M
P/E ratio 2021 33,8x
Yield 2021 0,94%
Sales 2022 164 B 1 441 M 1 441 M
Net income 2022 20 588 M 181 M 181 M
Net cash position 2022 112 B 981 M 981 M
P/E ratio 2022 32,4x
Yield 2022 0,96%
Capitalization 675 B 5 912 M 5 937 M
EV / Sales 2021 3,64x
EV / Sales 2022 3,44x
Nbr of Employees 3 473
Free-Float 62,3%
More Financials
Company
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others. 
Sector
Personal Products
Calendar
10/28Earnings Release
More about the company
Ratings of Kobayashi Pharmaceutical Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about KOBAYASHI PHARMACEUTICAL CO., LTD.
06/29KOBAYASHI PHARMACEUTICAL CO., LTD. : Ex-dividend day for interim dividend
FA
2020KOBAYASHI PHARMACEUTICAL CO., LTD. : Ex-dividend day for final dividend
FA
2020Kobayashi Pharmaceutical Co., Ltd. acquired Alva-Amco Pharmacal Companies, Inc. from Tr..
CI
2020KOBAYASHI PHARMACEUTICAL CO., LTD. : Ex-dividend day for interim dividend
FA
2020KOBAYASHI PHARMACEUTICAL CO., LTD.(T : 4967) added to S&P Japan Mid Cap 100
CI
2019KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
2019KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for interim dividend
FA
2019Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on..
CI
2019Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 31, 2019 has e..
CI
2019Kobayashi Pharmaceutical Co., Ltd. acquired Meitanhonpo.Co.,Ltd.
CI
2019Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on..
CI
2019Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,300,000 shares, re..
CI
2019Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
2018KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
2018Kobayashi Pharmaceutical Co., Ltd. completed the acquisition of True Nature Co., Ltd.
CI
More news
News in other languages on KOBAYASHI PHARMACEUTICAL CO., LTD.

- No features available -

More news
Chart KOBAYASHI PHARMACEUTICAL CO., LTD.
Duration : Period :
Kobayashi Pharmaceutical Co., Ltd. Technical Analysis Chart | 4967 | JP3301100008 | MarketScreener
Technical analysis trends KOBAYASHI PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Last Close Price 8 530,00 JPY
Average target price 9 712,22 JPY
Spread / Average Target 13,9%
EPS Revisions
Managers and Directors
Akihiro Kobayashi President & Representative Director
Noriaki Hirao Manager-Finance & Accounting
Kazumasa Kobayashi Chairman
Haruo Tsuji Independent Outside Director
Kunio Ito Independent Outside Director
Sector and Competitors